Page 41 - 《中国药房》2025年9期
P. 41
双术汤对大鼠的安全性及改善消化性不良的药效作用研究
Δ
3
2
6
1
2
2
1*
陈鑫源 ,熊常州 ,李炯汾 ,余康怡 ,徐 欢 ,王樱遐 ,廖 丹 ,陶俊宇 1, 4, 5 ,杨子仪 ,林才志 (1.广西中医
1
1, 7 #
药大学研究生院,南宁 530200;2.广西中医药大学赛恩斯新医药学院,南宁 530200;3.广西中医药大学基础
医学院,南宁 530200;4.广西高发传染病中西医结合转化医学重点实验室,南宁 530200;5.广西特色实验动
物病证模型重点实验室,南宁 530200;6.成都中医药大学针灸推拿学院,成都 610075;7.广西中医药大学第
一附属医院脾胃肝病科,南宁 530219)
中图分类号 R965;R285 文献标志码 A 文章编号 1001-0408(2025)09-1059-06
DOI 10.6039/j.issn.1001-0408.2025.09.07
摘 要 目的 研究双术汤对大鼠的安全性及其改善大鼠功能性消化不良(FD)的药效作用。方法 安全性实验方面:取40只大鼠
分为空白对照组和双术汤低、中、高剂量组[108、216、324 g/(kg·d),以生药量计,下同],每天给予相应药物,连续14 d;记录大鼠死
亡情况、毒性反应,计算大鼠肝、肾、脾、肺、心的脏器指数,观察肝、肾、脾、肺、心、胃、十二指肠、结肠的病理形态学变化,以评估双
术汤的急性毒性。另取40只大鼠同法分组、给药,连续30 d;记录大鼠死亡情况、毒性反应,计算相应脏器指数,观察相应脏器病
理形态学变化,检测血常规及血清生化指标水平,以评估双术汤的亚急性毒性。药效学实验方面:将50只大鼠分为空白对照组、
模型组和双术汤低、中、高剂量组(9.45、18.9、37.8 g/kg),每组10只;除空白对照组外,其余各组大鼠均通过皮下注射洛哌丁胺(3.5
mg/kg)制备FD大鼠模型;各组大鼠灌胃相应药液/生理盐水,每天1次,连续14 d。末次给药后,检测大鼠粪便含水率、小肠推进
率、胃排空率和血清中胃动素水平,观察大鼠结肠组织中卡哈尔间质细胞(ICC)的超微结构。结果 安全性实验结果显示:双术汤
各剂量组大鼠均未出现死亡,脏器指数、血常规及血清生化指标水平与空白对照组比较,差异均无统计学意义(P>0.05),各脏器
病理形态学观察未见异常。药效学实验结果显示:与空白对照组比较,模型组大鼠粪便含水率、胃排空率、小肠推进率、血清中胃
动素水平均显著降低(P<0.05);结肠组织中ICC线粒体重度肿胀、嵴消失,内质网扩张。与模型组比较,双术汤高剂量组大鼠上
述定量指标均显著升高(P<0.05);结肠组织中 ICC 有大量线粒体,且嵴清晰、排列规整。结论 双术汤具有较好的安全性,且对
FD大鼠具有较好的改善作用;其作用机制可能与调节胃肠激素表达以促进胃排空与肠推进,修复ICC线粒体结构以恢复胃肠功
能有关。
关键词 双术汤;安全性;药效学;急性毒性;亚急性毒性;消化性功能不良;胃肠动力障碍
Study on the safety and pharmacological effect on improving dyspepsia of Shuangshu decoction in rats
1
1
CHEN Xinyuan ,XIONG Changzhou ,LI Jiongfen ,YU Kangyi ,XU Huan ,WANG Yingxia ,LIAO Dan ,TAO
1
2
3
2
2
1, 7
Junyu 1, 4, 5 ,YANG Ziyi ,LIN Caizhi (1. School of Graduate, Guangxi University of Chinese Medicine, Nanning
6
530200, China;2. Faculty of Chinese Medicine Science, Guangxi University of Chinese Medicine, Nanning
530200, China;3. School of Basic Medicine, Guangxi University of Chinese Medicine, Nanning 530200,
China;4. Guangxi Key Laboratory of Translational Medicine for Treating High-incidence Infectious Diseases with
Integrative Medicine, Nanning 530200, China;5. Key Laboratory of Characteristic Experimental Animal Models
of Guangxi, Nanning 530200, China;6. School of Acupuncture-moxibustion and Tuina, Chengdu University of
Traditional Chinese Medicine, Chengdu 610075, China;7. Dept. of Spleen, Stomach and Hepatology, the First
Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning 530219, China)
ABSTRACT OBJECTIVE To study the safety of Shuangshu decoction in rats and its efficacy in improving functional dyspepsia
(FD) in rats. METHODS In safety test, 40 rats were divided into blank control group, Shuangshu decoction low-dose, medium-
dose and high-dose groups [108, 216, 324 g/(kg·d), calculated by raw medicine, the same applies below]; they were given
relevant medicine intragastrically, for continuous 14 days. The mortality and toxic reactions of rats were recorded, and the organ
indexes of the liver, kidney, spleen, lung and heart of rats were calculated; the pathological morphological changes in the liver,
kidney, spleen, lung, heart, stomach, duodenum, and colon
were observed to evaluate the acute toxicity of Shuangshu
Δ 基金项目 国家自然科学基金项目(No.82060834)
*第一作者 住院医师,硕士。研究方向:中医脾胃病的防治。 decoction. Another 40 rats were grouped and administered in
E-mail:839029828@qq.com the same way for 30 consecutive days. The mortality and toxic
# 通信作者 教授,硕士。研究方向:中医脾胃病的防治。E-mail: reactions of the rats were recorded, and the corresponding
lincaizhi710103@163.com organ indexes were calculated. The pathological morphological
中国药房 2025年第36卷第9期 China Pharmacy 2025 Vol. 36 No. 9 · 1059 ·